Prescribing trends of sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction

Eur Heart J Cardiovasc Pharmacother. 2023 Sep 20;9(6):505-506. doi: 10.1093/ehjcvp/pvad022.
No abstract available

Publication types

  • Letter

MeSH terms

  • Glucose
  • Heart Failure* / diagnosis
  • Heart Failure* / drug therapy
  • Humans
  • Sodium
  • Stroke Volume
  • Ventricular Dysfunction, Left*

Substances

  • Glucose
  • Sodium